Drug Channels Institute (DCI) is a leading provider of specialized management education and computer-based training for and about the pharmaceutical industry. >


DCI delivers educational solutions for clients that enhance the business acumen of employees, from senior executives to field reps to internal operations. State-of-the-art instructional design, coupled with extensive industry knowledge, allows DCI to build rigorous programs with accurate, fact-based content reflecting the latest developments. Even better, we deliver the material in an engaging, accessible manner using turn-key technology solutions. View a sample of our modules

View Sample

Industry Reports

The 2017 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

This completely updated, revised, and expanded analysis of the $360+ billion U.S. pharmacy industry thoroughly dissects its interactions with the U.S. healthcare system. more >

The 2016-17 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

The most comprehensive tool for analyzing the economic and business realities of $400 billion U.S. pharmaceutical distribution industry. more >

From The Drug Channels Blog

Diplomat Sees Declining DIR Fee Impact—and Perhaps Readies a PBM Strategy

Last week, Diplomat Pharmacy released its quarterly earnings, which included new details about the financial impact of Direct and Indirect Remuneration (DIR) fees. I provide some background on DIR fees more >

Electronic Benefit Verification & Prior Authorization Summit

Electronic Benefit Verification & Prior Authorization SummitOctober 24-25, 2017 | San Francisco, CAwww.cbinet.com/eBenefitCBI’s Electronic Benefit Verification & Prior Authorization Summit provides attendees with an understanding of key issues and developments more >